Business Context and Reporting Period
This Form 8-K is a current report filed by NanoVibronix, Inc. (trading symbol: NAOV) on June 17, 2021. The filing addresses a regulatory notice received from the Nasdaq Stock Market regarding the company's compliance with continued listing standards. Note: The metadata provided lists "Envue Medical, Inc.", but the filing text explicitly identifies the registrant as NanoVibronix, Inc.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. The only financial metric disclosed is the stock price performance triggering the regulatory notice:
- Minimum Bid Price Requirement: $1.00 per share.
- Observed Performance: The closing bid price remained below $1.00 for 30 consecutive business days between May 5, 2021, and June 16, 2021.
Material Changes
The material change reported is the receipt of a deficiency notice from Nasdaq under Listing Rule 5550(a)(2). The company failed to maintain the minimum bid price requirement for the specified 30-day period. There is no immediate impact on the listing status; the stock continues to trade on the Nasdaq Capital Market.
Guidance, Outlook, and Risks
Compliance Period: The company has been granted an initial 180-calendar-day compliance period ending December 14, 2021, to regain compliance.
Path to Compliance: To cure the deficiency, the common stock must maintain a minimum closing bid price of $1.00 for at least ten consecutive business days during the compliance period.
Contingencies and Risks:
- If the company fails to regain compliance by December 14, 2021, it may be eligible for an additional 180-day period if it meets other listing standards (excluding bid price) and intends to effect a reverse stock split.
- There is no assurance the company will be able to regain compliance or avoid delisting.
- If the company is unable to cure the deficiency or is ineligible for an extension, Nasdaq will issue a notice of delisting.
Investor Verification Checklist
- Verify the current trading price of NAOV to assess proximity to the $1.00 threshold.
- Monitor the company's stock price for ten consecutive days of closing at or above $1.00 before December 14, 2021.
- Review future filings for announcements regarding a potential reverse stock split if the initial compliance period expires without a price cure.
- Confirm the company's status on the Nasdaq Capital Market to ensure no delisting notice has been issued.